Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ballen

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell TransplantationDaniel R Reed, Gina R Petroni, Melissa West, et al.
Blood|April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomesClaudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Bone Marrow Transplantation|May 1, 2007
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimenB R Dey, J Shaffer, A J Yee, et al.
Blood Advances|January 4, 2018
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host diseaseZachariah DeFilipp, Rosalynn M Nazarian, Areej El-Jawahri, et al.
American Journal of Hematology|June 18, 2011
Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITDHarshabad Singh, Lillian L Werner, Salma Asali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemiaWilliam A Wood, Stephanie J Lee, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell TransplantationDaniel R Reed, Gina R Petroni, Melissa West, et al.
Blood|April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomesClaudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Bone Marrow Transplantation|May 1, 2007
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimenB R Dey, J Shaffer, A J Yee, et al.
Blood Advances|January 4, 2018
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host diseaseZachariah DeFilipp, Rosalynn M Nazarian, Areej El-Jawahri, et al.
American Journal of Hematology|June 18, 2011
Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITDHarshabad Singh, Lillian L Werner, Salma Asali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemiaWilliam A Wood, Stephanie J Lee, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 17